Global blockbuster fat-busting injection Mounjaro became India's top-selling medicine brand within months of its launch ...

The Mumbai-based drugmaker, in a regulatory filing, said it has the rights to distribute and promote Yurpeak, the second anti ...

The much-awaited anti-diabetes and weight-loss drug Mounjaro, developed by US pharmaceutical giant Eli Lilly, was launched in India on March 20. This once-a-week prescription-based medicine helps ...

Novo Nordisk has launched its blockbuster diabetes drug Ozempic in India, pricing the starter dose at ₹8,800 per month (₹2,200 per week), positioning it as a competitor to Eli Lilly's Mounjaro (priced ...

In November, Mounjaro clocked Rs 108 crore in sales, making it the number 1 brand in the IPM, reflecting sustained momentum ...

(Reuters) -Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) for its starting dose of 2.5 mg in India, stepping ...

HYDERABAD (Reuters) -Sales of Danish drugmaker Novo Nordisk's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month earlier, data from research firm Pharmarack showed on ...

Looking to expand its footprint in the booming glucagon-like peptide (GLP-1) market, Danish drugmaker Novo Nordisk has ...

India's GLP-1 race intensifies with the launch of Ozempic ...

Eli Lilly (NYSE:LLY) said on Thursday that India’s drug regulator has approved the launch of its Mounjaro pre-filled injector pens, expanding its options in the growing weight-loss drug market and ...

HYDERABAD (Reuters) - An Indian government-approved expert panel has advised the country's drug regulator to approve the import and sale of U.S. drugmaker Eli Lilly's Mounjaro, a blockbuster diabetes ...

A steep price drop for Wegovy and strong uptake of Mounjaro pushed GLP-1 weight-loss drugs to new highs in November. The ...